Skip to main content

Jury Still Out on Schumer and Bloomberg's Eiffel Towering of SarbOx, IPO Market

  • Author:
  • Updated:

The latest string of Schumer and Bloomberg refutations are out (even since the opening bell), concerning the dynamic duo’s alarmist report about the impending decline of NYC’s financial dominance due to SarbOx and precluded by mass IPO relocation. To summarize a couple recent responses: The New Yorker’s Financial Page argues that the IPO migration is mostly a byproduct of large-scale privatization of former foreign government enterprise and SarbOx hasn’t hurt the market, evident by its growth. Adam Lashinsky of Fortune takes this stance one step further, pointing to the growth in the number of venture backed companies that went public in the U.S. in 2006 and the increase in the amount of money raised by domestic IPOs per IPO. Lashinsky also says the strength of the U.S. IPO market is self-evident in fact that some of the largest tech IPOs are still looking to trade on U.S. exchanges, not foreign ones.
IPOs still love U.S. markets – [Fortune via CNNMoney]
Over There – [New Yorker]